Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the ...
WASHINGTON, Nov 6 (Reuters) - U.S. President Donald Trump, Eli Lilly (LLY.N), opens new tab and Novo Nordisk (NOVOb.CO), opens new tab unveiled a deal on Thursday to slash the prices of popular GLP-1 ...
Novo Nordisk made a much higher offer to acquire a biotech Pfizer was already set to buy out. Losing this battle would be more damaging to Pfizer than to Novo Nordisk. Even so, both companies look ...
Novo Nordisk is a major drugmaker offering treatments for diabetes and weight loss. Those are two conditions affecting millions of Americans. It has some promising new treatments in development, as ...
I’ve tried my fair share of gacha games, and even gotten hooked on a few — I’m still salty to this day that I’ve never pulled a Kitasan Black card in Umamusume: Pretty Derby. While it is technically ...
COPENHAGEN, Sept 17 (Reuters) - A senior Novo Nordisk (NOVOb.CO), opens new tab executive on Wednesday described the drugmaker's ongoing trial of its blockbuster obesity medicine for treatment of ...
FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the ...
Third Person Shooters Embark makes free-to-play Arc Raiders sound like a nightmare, says its $40 price let it cut a lot of un-fun crap: "Crafting no longer has timers on it that you have to wait out" ...
As part of an effort to improve access to authentic versions of its GLP-1 medications, Novo Nordisk is cutting the cost of its popular diabetes drug Ozempic by nearly half. In an Aug. 18 press release ...
With a new endorsement from the FDA, Novo Nordisk’s Wegovy has picked up its third indication and become the second drug approved in a severe form of fatty liver disease. Shortly after market close ...
Novo Nordisk's shares have dropped significantly despite appealing Q2 results, creating an attractive entry point for long-term investors. The company continues to deliver double-digit revenue and ...